CD83 and Alzheimer disease: The capacity of HCMV to induce molecular precursors of AD molecular pathology in an organoid model system may also explain our previous observation of increased neurofibrillary tangle and neuritic plaque pathology in CD83(+) AD subjects compared with CD83(−) AD subjects within the ROSMAP cohort.4